KN052

· Jiangsu Alphamab Biopharmaceuticals Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KN052, covering 2024-05-01 to 2024-05-01. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of KN052 in Chinese Subjects With Advanced Solid Tumors [Phase 1]